Published in Cancer Weekly, November 19th, 2002
In addition, it may be able to prevent the establishment of new tumors from cancer cells seeded during colorectal surgery, according to animal studies performed in Taiwan.
Medical researchers at National Taiwan University Hospital recently issued a report that concluded granulocyte-macrophage colony-stimulating factor (GM-CSF) gene therapy prevents and reduces rectal cancers in murine cancer models.
All untreated mice that were implanted with CT-26 murine cancer cells...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.